（4-丁氧基苯甲基）三苯基溴化磷 | 146346-92-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: （4-丁氧基苯甲基）三苯基溴化磷
• 中文别名: (4-N-丁氧基苄基)三苯基溴化膦；(4-丁氧基苯甲基)三苯基溴化磷
• 英文名称: (4-butyloxyphenyl)methyl-triphenylphosphonium bromide
• 英文别名: (4-butoxybenzyl)-triphenylphosphonium bromide；(4-Butoxybenzyl)triphenylphosphonium bromide；(4-butoxyphenyl)methyl-triphenylphosphanium;bromide
• CAS: 146346-92-1
• 化学式: Br*C₂₉H₃₀OP
• 分子量: 505.434
• InChiKey: DYBCXFJUMGEGBX-UHFFFAOYSA-M

物化性质

• 熔点：
  195-198 °C(lit.)

计算性质

• 辛醇/水分配系数(LogP)：
  3.36
• 重原子数：
  32
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• 安全说明：
  S26,S36

反应信息

• 作为反应物：
  描述：

  4-丁氧基苯甲醛 、 （4-丁氧基苯甲基）三苯基溴化磷 在 sodium ethanolate 作用下， 以 乙醇 为溶剂， 生成 (E)-4,4’-dibutoxystilbene
  参考文献：
  名称：

  Alkoxylated p-phenylenevinylene oligomers: Synthesis and spectroscopic and electrochemical properties

  摘要：

  Twenty-one n-alkoxy substituted phenylenevinylene oligomers were synthesized, varying in size, number and position of the OR groups. IR,MS and solubility data are presented. NMR measurements provided the molecular structure as well as information about conformations and molecular dynamics. UV and of cyclic voltammetric data give correlations of chemical structure (number and position of OR substituents) with separate HOMO and LUMO energies. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0040-4020(97)00871-5
• 作为产物：
  描述：

  1-丁氧基-4-甲基-苯 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 xylene 为溶剂， 生成 （4-丁氧基苯甲基）三苯基溴化磷
  参考文献：
  名称：

  Alkoxylated p-phenylenevinylene oligomers: Synthesis and spectroscopic and electrochemical properties

  摘要：

  Twenty-one n-alkoxy substituted phenylenevinylene oligomers were synthesized, varying in size, number and position of the OR groups. IR,MS and solubility data are presented. NMR measurements provided the molecular structure as well as information about conformations and molecular dynamics. UV and of cyclic voltammetric data give correlations of chemical structure (number and position of OR substituents) with separate HOMO and LUMO energies. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0040-4020(97)00871-5

文献信息

• Catalyst for decarbonylation reaction
  申请人：UBE INDUSTRIES, LTD.

  公开号：EP0826658A1

  公开（公告）日：1998-03-04

  A catalyst composed of an organic phosphorus compound having a trivalent or pentavalent phosphorus atom and at least one carbon-phosphorus bonding or a combination of the organic phosphorus compound and a halogen atom-containing compound is effective for decarbonylation, that is, for releasing carbon monoxide from a compound containing a moiety of -CO-CO-O- in its molecular structure.

  一种由含有三价或五价磷原子的有机磷化合物和至少一个碳-磷键合或有机磷化合物与含卤原子的化合物的组合构成的催化剂对于脱羰基作用是有效的，即从含有分子结构中的-CO-CO-O-基团的化合物中释放一氧化碳。
• Quinclidine derivatives as squalene synthase inhibitors
  申请人：Zeneca Limited

  公开号：US05691349A1

  公开（公告）日：1997-11-25

  Quinuclidine derivatives of formula, and their pharmaceutically acceptable salts, in which: R.sup.1 is hydrogen or hydroxy; R.sup.2 is hydrogen; pr R.sup.1 and R.sup.2 are joined together so that CR.sup.1 -CR.sup.2 is a double bond; X is selected from --CH.sub.2 CH.sub.2 --, --CH.dbd.CH--, --C.dbd.C--, --CH.sub.2 O--, --OCH.sub.2 --, --CH.sub.2 NH--, NHCH.sub.2 --, --CH.sub.2 CO--, --COCH.sub.2 --, --CH.sub.2 S(O).sub.n -- and --S(O).sub.n CH.sub.2 -- wherein n is 0, 1 or 2; and AR is phenyl which may be optionally unsubstituted or substituted by one or more substituents such as halogeno, hydroxy, amino, nitro, cyano, carboxy, carbamoyl, alkyl, alkenyl, alkynyl, alkoxy, alkylamino, dialkylamino, N-alkylcarbamoyl, N,N-di-alkylcarbamoyl, alkoxycarbonyl, alkythio, alkylsulphinyl, alkylsulphonyl, halogeno alkyl, alkanoylamino, alkylenedioxy, alkanoyl and oxime derivatives thereof and O-alkyl ethers of said oximes; provided that when X is selected from --OCH.sub.2 --, --NHCH.sub.2 --, and SCH.sub.2 --, R.sup.1 is not hydroxy; inhibit squalene synthase and are useful in treating diseases or medical conditions in which inhibition of squalene synthase is desirable. The use of such heterocyclic derivatives in treating conditions such as hypercholesterolemia, and atherosclerosis is referred to as well as novel compounds, processes for their preparation and pharmaceutical compositions containing them.

  喹诺克林衍生物的公式，以及它们的药用可接受盐，其中：R.sup.1是氢或羟基；R.sup.2是氢；或者R.sup.1和R.sup.2连接在一起，使得CR.sup.1-CR.sup.2是一个双键；X选自--CH.sub.2 CH.sub.2 --, --CH.dbd.CH--, --C.dbd.C--, --CH.sub.2 O--, --OCH.sub.2 --, --CH.sub.2 NH--, NHCH.sub.2 --, --CH.sub.2 CO--, --COCH.sub.2 --, --CH.sub.2 S(O).sub.n --和--S(O).sub.n CH.sub.2 --，其中n为0、1或2；AR是苯基，它可以是未取代的，也可以是取代的，取代基可以是卤素、羟基、氨基、硝基、氰基、羧基、氨基甲酰基、烷基、烯基、炔基、烷氧基、烷基氨基、二烷基氨基、N-烷基氨基甲酰基、N，N-二烷基氨基甲酰基、烷氧基羰基、烷基硫、烷基亚磺酰基、烷基亚磺酰基、卤代烷基、烷酰氨基、烷二氧基、烷酰和肟衍生物以及所述肟的O-烷基醚；当X选自--OCH.sub.2 --, --NHCH.sub.2 --和--SCH.sub.2 --时，R.sup.1不是羟基；抑制角鲨烯合酶，在抑制角鲨烯合酶是可取的情况下，用于治疗疾病或医疗状况。此类杂环衍生物在治疗高胆固醇血症和动脉粥样硬化等状况中的应用，以及新的化合物、它们的制备过程和含有它们的药物组合物。
• Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
  申请人：——

  公开号：US20020128263A1

  公开（公告）日：2002-09-12

  This invention relates to a compound and the use of the compound of the formula 1 wherein R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the description, A signifies —CH═CH— or —C≡C—; and B signifies 2 wherein R 6 to R 26 , X and Y are as defined in the specification or a pharmaceutically acceptable salt thereof, for use in pharmaceutical compositions for the treatment or prevention of mGluR5 receptor mediated disorders.

  本发明涉及一种化合物及该化合物的使用，其化学式为1，其中R1、R2、R3、R4和R5如描述中所定义，A表示—CH═CH—或—C≡C—；B表示2，其中R6到R26、X和Y如规范中所定义或其药用可接受的盐，用于制备用于治疗或预防mGluR5受体介导的疾病的制药组合物。
• Cyclohexane compounds used in liquid crystalline mixtures
  申请人：Hoffmann-La Roche Inc.

  公开号：US05346647A1

  公开（公告）日：1994-09-13

  Compounds of the formula ##STR1## wherein n stands for the number 0 or 1; R.sup.1 denotes a group R.sup.3 or R.sup.3 --A.sup.3 --Z.sup.2 -- and R.sup.2 denotes a group R.sup.4 or R.sup.4 --A.sup.4 --Z.sup.3 --; ring A.sup.1 is unsubstituted or halogen-, cyano- and/or methylsubstituted 1,4-phenylene in which optionally 1 CH group or 2 CH groups is/are replaced by nitrogen; A.sup.3 A.sup.4 and ring A.sup.2 each independently represent unsubstituted or halogen-, cyano- and/or methyl- -substituted 1,4-phenylene in which optionally 1 CH group or 2 CH groups is/are replaced by nitrogen or trans-1,4-cyclohexylene, trans-1,3-dioxane-2,5-diyl, 1-cyano-trans-1,4-cyclohexylene, bicyclo[2.2.2]octane- -1,4-diyl, naphthalene-2,6-diyl, tetralin-2,6-diyl or trans-decalin-2,6- diyl; Z.sup.1, Z.sup.2 and Z.sup.3 each independently are a single covalent bond, --COO--, --OOC--, --CH.sub.2 O--, --OCH.sub.2 --, --CH.sub.2 CH.sub.2 --, --C.vertline.C--, --(CH.sub.2).sub.3 O--, --O(CH.sub.2).sub.3 --, --(CH.sub.2).sub.4 -- or the trans form of --CH.dbd.CH-- CH.sub.2 O-- or --OCH.sub.2 --CH.dbd.CH--; R.sup.3 and R.sup.4 each independently denote halogen, cyano, --NCS, --CF.sub.3, --OCF.sub.3 or alkyl in which optionally one >CH--CH< is replaced by >C.dbd.C< and/or optionally one methylene group or two non- adjacent methylene groups is/are replaced by --O--, --COO-- and/or --OOC-- and/or optionally one methylene group is replaced by --CHX--; and X is halogen, cyano or methyl, as well as liquid crystalline mixtures which contain such compounds and their use for electro-optical purposes.

  化合物的公式为##STR1##其中n代表数字0或1; R.sup.1表示R.sup.3或R.sup.3 - A.sup.3 - Z.sup.2 -基团，R.sup.2表示R.sup.4或R.sup.4 - A.sup.4 - Z.sup.3 -基团; 环A.sup.1是未取代或卤素，氰基和/或甲基取代的1,4-苯撑基，在其中可以选择将1个CH基团或2个CH基团替换为氮; A.sup.3，A.sup.4和环A.sup.2各自独立地表示未取代或卤素，氰基和/或甲基取代的1,4-苯撑基，在其中可以选择将1个CH基团或2个CH基团替换为氮或反-1,4-环己撑基，反-1,3-二氧杂环戊烷-2,5-二基，1-氰基-反-1,4-环己撑基，双环[2.2.2]辛烷-1,4-二基，萘-2,6-二基，四氢萘-2,6-二基或反-癸烷-2,6-二基; Z.sup.1，Z.sup.2和Z.sup.3各自独立地为单个共价键，-COO-，-OOC-，-CH.sub.2 O-，-OCH.sub.2 -，-CH.sub.2 CH.sub.2 -，-C.vertline.C-，-(CH.sub.2).sub.3 O-，-O(CH.sub.2).sub.3 -，-(CH.sub.2).sub.4-或-CH.dbd.CH-CH.sub.2 O-或-OCH.sub.2-CH.dbd.CH-的反式形式; R.sup.3和R.sup.4各自独立地表示卤素，氰基，-NCS，-CF.sub.3，-OCF.sub.3或烷基，其中可以选择一个>CH-CH<被>C.dbd.C<替换，和/或可以选择一个亚甲基或两个非相邻亚甲基被替换为-O-，-COO-和/或-OOC-，和/或可以选择一个亚甲基被替换为-CHX-; X是卤素，氰基或甲基，以及包含这些化合物的液晶混合物及其用途，用于电光目的。
• PHOTOACTIVABLE NITROGEN BASES
  申请人：Dietliker Kurt

  公开号：US20100105794A1

  公开（公告）日：2010-04-29

  Compounds of the Formula (I), (II) and (III) wherein Ar is for example phenylene, biphenylene or naphthylene, all of which are unsubstituted or substituted by C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, CN, OR 11 , SR 11 , CH2OR 11 , COOR 12 , CONR 12 R 13 or halogen; R 1 , R 2 , R 7 and R 8 independently of one another other are hydrogen or C 1 -C 6 -alkyl; R 3 and R 5 together and R 4 and R 6 together form a C 2 -C 6 -alkylene bridge which is unsubstituted or substituted by one or more C 1 -C 4 -alkyl; R 11 is hydrogen or C 1 -C 6 -alkyl; R 12 and R 13 independently of one another for example are hydrogen, phenyl, C 1 -C 18 -alkyl, C 1 -C 18 -alkyl which is interrupted by one or more O; n is 1-10; X is O, S or NR 10 ; A and A 1 are suitable linking groups; are suitable as photolatent bases.

  公式(I)、(II)和(III)的化合物，其中Ar可以是苯基、联苯基或萘基，它们都可以是未取代或被C1-C4烷基、C2-C4烯基、CN、OR11、SR11、CH2OR11、COOR12、CONR12R13或卤素取代的；R1、R2、R7和R8独立地是氢或C1-C6烷基；R3和R5在一起，R4和R6在一起形成一个未取代或被一个或多个C1-C4烷基取代的C2-C6烷基桥；R11是氢或C1-C6烷基；R12和R13独立地可以是氢、苯基、C1-C18烷基、被一个或多个O中断的C1-C18烷基；n为1-10；X为O、S或NR10；A和A1是适当的连接基团；它们适用于光致潜基。

表征谱图